← Back to Search

Telemedicine Referral for Childhood Hearing Loss

N/A
Recruiting
Led By Susan Emmett, MD, MPH
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up proportion of children who receive follow-up will be measured by the occurrence of an ear/hearing encounter, up to 60 days from the date of screening.
Awards & highlights

Study Summary

This trial will test whether a new telemedicine intervention called STAR can reduce loss to follow-up in rural Alaska after school hearing screenings. It will compare the intervention to the standard referral of a letter home to families, and evaluate over three academic years.

Who is the study for?
This trial is for children in grades K-12 attending participating schools in rural Alaska regions. It aims to address high rates of childhood hearing loss, which is often preventable and related to infections.Check my eligibility
What is being tested?
The study compares two methods: the standard referral process versus a telemedicine intervention called STAR, which brings specialty care directly into schools after mobile health screenings.See study design
What are the potential side effects?
Since this trial involves screening and referral processes rather than medical treatments or drugs, there are no direct side effects associated with the interventions being tested.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~proportion of children who receive follow-up will be measured by the occurrence of an ear/hearing encounter, up to 60 days from the date of screening.
This trial's timeline: 3 weeks for screening, Varies for treatment, and proportion of children who receive follow-up will be measured by the occurrence of an ear/hearing encounter, up to 60 days from the date of screening. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of children who receive follow-up

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard ReferralExperimental Treatment1 Intervention
Group II: Specialty Telemedicine Access for Referrals (STAR)Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
486 Previous Clinical Trials
144,308 Total Patients Enrolled
3 Trials studying Hearing Loss
14,429 Patients Enrolled for Hearing Loss
Southcentral FoundationOTHER
6 Previous Clinical Trials
629 Total Patients Enrolled
Duke UniversityOTHER
2,364 Previous Clinical Trials
3,414,597 Total Patients Enrolled
8 Trials studying Hearing Loss
47,539 Patients Enrolled for Hearing Loss

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is eligibility for this experiment restricted to adults?

"The requisite age range for joining this trial is 3 to 21 years old. 59 studies are available for minors, while 146 cater to senior citizens."

Answered by AI

Are there any eligibility criteria I must meet in order to participate in this experiment?

"This research study is seeking 6045 people aged 3-21 who suffer from hearing loss. Additionally, they must be students enrolled in one of the participating schools within three geographic regions and their grade level (K-12) should comply with the normal screening process for those schools. There are no age, gender, racial or ethnic constraints on eligibility."

Answered by AI

Is there still an opportunity to join this research endeavor?

"Indeed, per the information on clinicaltrials.gov this medical research is still recruiting participants. It was initially posted on September 1st 2023 and edited October 24th of that same year. 6045 patients are sought by one location for inclusion in the study."

Answered by AI

What is the total enrollment number for this experiment?

"Affirmative. Data available on clinicaltrials.gov attests that this trial, which was originally posted on September 1st 2023 is now actively recruiting patients. The medical study seeks to enrol 6045 individuals across a single site."

Answered by AI
~4030 spots leftby May 2026